Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Can someone with glucoma take plaquenil Fda plaquenil PLAQUENIL® HYDROXYCHLOROQUINE SULFATE TABLETS, USP DESCRIPTION PLAQUENIL h. ydroxychloroquine sulfate is a. white or practically white, crystalline. powder freely. soluble in water; practically insoluble in alcohol, chloroform, and in ether. The. chemical. name for. Reports of Practical Oncology and Radiotherapy is a bimonthly interdisciplinary journal that publishes original contributions in clinical and radiation oncology as well as in radiotherapy physics, techniques, and equipment. The journal welcomes original research papers, review articles, preliminary communications, technical notes, and novel case reports, as well as letters to the editor on. Does Plaquenil Interact with other Medications? Severe Interactions. These medications are not usually taken together. Consult your healthcare professional e.g. doctor or pharmacist for more in. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Plaquenil and radiotherapy Management Considerations in Cancer Patients With., Reports of Practical Oncology and Radiotherapy - Journal. Sarcoidosis treatment usmle hydroxychloroquineSide effects of too much plaquenilHydroxychloroquine sulfate teaching Find patient medical information for Plaquenil Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Plaquenil Oral Uses, Side Effects, Interactions.. Plaquenil Oral Interactions with Other Medication. Will you have Radiation pneumonitis with Plaquenil - eHealthMe. To examine the outcomes of concurrent versus sequential whole-brain radiotherapy WBRT and epidermal growth factor receptor-tyrosine kinase inhibitor EGFR-TKI in nonsmall cell lung cancer NSCLC patients with EGFR mutation. Retrospectively 105 patients. Objective To assess the efficacy of chloroquine Aralen phosphate and hydroxychloroquine Plaquenil sulfate in the treatment of patients with neurosarcoidosis who either do not respond to corticosteroid therapy or develop unacceptable side effects. Design Retrospective study. Background Hydroxychloroquine sulfate and other antimalarial drugs have been used successfully as adjunctive therapy for patients with cutaneous lesions of dermatomyositis over the past 20 years. An increased incidence of cutaneous reactions to hydroxychloroquine has been postulated to occur.